Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 276.00
Bid: 271.00
Ask: 276.00
Change: -1.00 (-0.36%)
Spread: 5.00 (1.845%)
Open: 277.00
High: 280.00
Low: 274.00
Prev. Close: 277.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS SUMMARY: CVS Group CEO Halves Stake

Fri, 10th Apr 2015 13:02

Director Dealings Summary - Week Ended April 10        
Company Name Position Number of Shares Resulting Holding *Note GBP Value
             
             
BUYS            
             
Hutchison China MediTech  Simon To Chairman 58,000 127,000   800,000
Strategic Minerals John Peters Chairman 1 million 1 million First purchase. 600,000
Hutchison China MediTech  Edith Shih Non-Executive Director 12,000 60,000   166,000
Hydrodec Andrew Black Non-Executive Director 1,750,000 183.6 million Day after Hydrodec agreed to buy Eco-Oil International for GBP2.4 million. 121,000
Dunedin Enterprise Investment Trust Duncan Budge Chairman 20,000 35,900 Week after making GBP5 million investment in Blackrock Programme Management. 68,000
Amerisur Resources John Wardle CEO 248,000 17.6 million Purchased by Tracarta in which Wardle has a beneficial interest. 60,000
Amerisur Resources Douglas Ellenor Non-Executive Director 200,000 1.2 million Same day as pretax profit fell during 2014 and revenue was offset by impairment charge. 50,000
Chime Communications Mervyn Davies Chairman 17,936 67,785   50,000
Synety Graham Ward Non-Executive Director 28,075 234,870 2 days after share placing and open offer. 25,000
JPMorgan Brazil Investment Trust Victor Bulmer-Thomas Non-Executive Director 43,750 159,850   24,000
Hydrodec Colin Moynihan Chairman 310,155 10.2 million Day after Hydrodec agreed to buy Eco-Oil International for GBP2.4 million. 20,000
Xaar Edmund Creutzmann CTO 4,846 4,846 First purchase. 20,000
Dunedin Enterprise Investment Trust Federico Marescott Director 6,000 10,000 Week after making GBP5 million investment in Blackrock Programme Management. 20,000
Synectics Peter Rae Non-Executive Director 14,000 232,302   18,000
Michelmersh Frank Hanna Commercial Director 21,985 1.3 million 2 weeks after reinstating its dividend payout. 15,000
Hydrodec Ian Smale CEO 200,000 1.1 million Day after Hydrodec agreed to buy Eco-Oil International for GBP2.4 million. 14,000
Amerisur Resources Nick Harrison CFO 50,000 5.7 million Same day as pretax profit fell during 2014 and revenue was offset by impairment charge. 12,000
Standard Life Elizabeth Noel Harwerth Non-Executive Director 1,893 10,074   8,900
Concurrent Technologies David Evans-Hughes Engineering Director 8,755 948,206   3,900
             
             
SELLS            
             
Amec Foster Wheeler Kent Masters Non-Executive Director 347,273 70,000 (in the form of ADRs) Week after winning EDF Energy UK nuclear power station deal. 3,800,000
CVS Group Simon Innes CEO 300,000 246,475 Sold more than half his stake. 1,700,000
Domino Printing Sciences  Peter Byrom Chairman 11,932  338,000   111,000
             
             
*Note: A recent company event around the time of the dealing does not suggest the dealing took place because of that event. When a spouse or related party to a director buys shares, the resulting holding is the beneficial holding of the director.
 
             
Contact: +44 207 199 0340; newsroom@alliancenews.com; @AllNewsTeam      
             
Copyright 2015 Alliance News Limited. All Rights Reserved.        

More News
6 Sep 2021 09:37

Hutchmed China to trade in Shanghai and Shenzhen through link scheme

Hutchmed China to trade in Shanghai and Shenzhen through link scheme

Read more
26 Aug 2021 10:38

Hutchmed launches trial into drug combination to treat breast cancer

Hutchmed launches trial into drug combination to treat breast cancer

Read more
9 Aug 2021 12:35

Hutchmed strikes collaboration deal with Epizyme

(Sharecast News) - Commercial-stage biotechnology company Hutchmed China announced a collaboration to research, develop, manufacture and commercialise 'Tazverik' in Greater China on Monday, including mainland China, Hong Kong, Macau and Taiwan.

Read more
9 Aug 2021 10:06

Hutchmed to partner with Epizyme on tumour-targetting treatment

Hutchmed to partner with Epizyme on tumour-targetting treatment

Read more
28 Jul 2021 14:51

Hutchmed research costs deepen loss; expects US launches in 2022, 2023

Hutchmed research costs deepen loss; expects US launches in 2022, 2023

Read more
28 Jul 2021 11:33

IN BRIEF: Hutchmed and AstraZeneca launch phase two cancer med trial

IN BRIEF: Hutchmed and AstraZeneca launch phase two cancer med trial

Read more
28 Jul 2021 10:58

AIM WINNERS & LOSERS: Hutchmed notes phase 2 trial; Tricorn drops 25%

AIM WINNERS & LOSERS: Hutchmed notes phase 2 trial; Tricorn drops 25%

Read more
21 Jul 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
16 Jul 2021 11:19

AIM WINNERS & LOSERS: Pantheon up on resource upgrade, farmout talks

AIM WINNERS & LOSERS: Pantheon up on resource upgrade, farmout talks

Read more
16 Jul 2021 10:55

IN BRIEF: Hutchmed tumor drug qualifies for formal review by EU agency

IN BRIEF: Hutchmed tumor drug qualifies for formal review by EU agency

Read more
13 Jul 2021 15:42

Hutchmed makes first commercial sale of 'Orpathys' in China

(Sharecast News) - Hutchmed China announced the first commercial sale in China of 'Orpathys', or savolitinib, on Tuesday, which is its "oral, potent, and highly-selective" small molecule inhibitor of MET, a receptor tyrosine kinase.

Read more
13 Jul 2021 14:06

TRADING UPDATES: Smiths gets Euros sticker boost; Hotel Chocolat grows

TRADING UPDATES: Smiths gets Euros sticker boost; Hotel Chocolat grows

Read more
6 Jul 2021 20:38

TRADING UPDATES: Hipgnosis placing oversubscribed; Creightons delays

TRADING UPDATES: Hipgnosis placing oversubscribed; Creightons delays

Read more
1 Jul 2021 19:26

TRADING UPDATES: Gym Group bulks up with placing; 88 Energy debt free

TRADING UPDATES: Gym Group bulks up with placing; 88 Energy debt free

Read more
30 Jun 2021 19:14

TRADING UPDATES: Topps Tiles improves as curbs ease; Bermele makes buy

TRADING UPDATES: Topps Tiles improves as curbs ease; Bermele makes buy

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.